J. Mark Gibson

1.2k total citations
17 papers, 416 citations indexed

About

J. Mark Gibson is a scholar working on Neurology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, J. Mark Gibson has authored 17 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 6 papers in Genetics. Recurrent topics in J. Mark Gibson's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Nuclear Receptors and Signaling (5 papers) and RNA regulation and disease (4 papers). J. Mark Gibson is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Nuclear Receptors and Signaling (5 papers) and RNA regulation and disease (4 papers). J. Mark Gibson collaborates with scholars based in United States, Ireland and Norway. J. Mark Gibson's co-authors include Timothy Lynch, Owen A. Ross, Matthew J. Farrer, Michael G. Heckman, Ryan J. Uitti, Jan Aasly, Zbigniew K. Wszołek, David Gosal, Carles Vilariño‐Güell and Christian Wider and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and Movement Disorders.

In The Last Decade

J. Mark Gibson

15 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Mark Gibson United States	11	267	161	156	110	67	17	416
Roya Saffary United States	6	194 0.7×	135 0.8×	185 1.2×	46 0.4×	41 0.6×	9	371
Bavo Heeman Belgium	9	193 0.7×	118 0.7×	262 1.7×	77 0.7×	145 2.2×	10	492
Pilar Casquero Spain	10	168 0.6×	70 0.4×	113 0.7×	50 0.5×	37 0.6×	11	366
Lemuel Racacho Canada	14	192 0.7×	164 1.0×	262 1.7×	49 0.4×	66 1.0×	18	547
Hatice Karasoy Türkiye	10	131 0.5×	88 0.5×	147 0.9×	52 0.5×	41 0.6×	26	332
Lumine Matsumoto Japan	5	152 0.6×	130 0.8×	206 1.3×	50 0.5×	36 0.5×	6	373
Esteban Luna United States	7	262 1.0×	155 1.0×	186 1.2×	55 0.5×	129 1.9×	7	458
Jun‐Hui Yuan Japan	13	93 0.3×	314 2.0×	210 1.3×	133 1.2×	90 1.3×	48	522
Erik Simons Netherlands	13	548 2.1×	194 1.2×	239 1.5×	256 2.3×	157 2.3×	17	786
Melissa A. Hayes United States	5	198 0.7×	145 0.9×	143 0.9×	40 0.4×	179 2.7×	7	406

Countries citing papers authored by J. Mark Gibson

Since Specialization

Citations

This map shows the geographic impact of J. Mark Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mark Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mark Gibson more than expected).

Fields of papers citing papers by J. Mark Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mark Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mark Gibson. The network helps show where J. Mark Gibson may publish in the future.

Co-authorship network of co-authors of J. Mark Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mark Gibson. A scholar is included among the top collaborators of J. Mark Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mark Gibson. J. Mark Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Gibson, J. Mark, et al.. (2025). Validation of Clinical-Grade Electroporation Systems for CRISPR-Cas9-Mediated Gene Therapy in Primary Hepatocytes for the Correction of Inherited Metabolic Liver Disease. Cells. 14(10). 711–711.

Gibson, J. Mark, et al.. (2013). A Project-Centric Course on Cyberinfrastructure to Support High School STEM Education. SHILAP Revista de lepidopterología.

Wider, Christian, Carles Vilariño‐Güell, Michael G. Heckman, et al.. (2010). SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study. European Journal of Neurology. 18(6). 876–881. 29 indexed citations

Soto‐Ortolaza, Alexandra I., Bahareh Behrouz, Christian Wider, et al.. (2009). Calbindin‐1 association and Parkinson’s disease. European Journal of Neurology. 17(2). 208–211. 10 indexed citations

Wider, Christian, Sarah Lincoln, Michael G. Heckman, et al.. (2009). Phactr2 and Parkinson's disease. Neuroscience Letters. 453(1). 9–11. 20 indexed citations

Wider, Christian, Carles Vilariño‐Güell, Barbara Jasińska‐Myga, et al.. (2009). Association of the MAPT locus with Parkinson’s disease. European Journal of Neurology. 17(3). 483–486. 45 indexed citations

Haugarvoll, Kristoffer, Mathias Toft, Lisa Skipper, et al.. (2008). Fine-mapping and candidate gene investigation within the PARK10 locus. European Journal of Human Genetics. 17(3). 336–343. 27 indexed citations

Ross, Owen A., Alexandra I. Soto, Carles Vilariño‐Güell, et al.. (2008). Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism & Related Disorders. 14(7). 539–543. 53 indexed citations

Ross, Owen A., Michael G. Heckman, Alexandra I. Soto, et al.. (2008). Dopamine β-hydroxylase −1021C>T association and Parkinson's disease. Parkinsonism & Related Disorders. 14(7). 544–547. 10 indexed citations

10.

Ross, Owen A., Kristoffer Haugarvoll, Jeremy T. Stone, et al.. (2007). Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism & Related Disorders. 13(7). 386–388. 4 indexed citations

11.

Toft, Mathias, Ignácio F. Mata, Owen A. Ross, et al.. (2007). Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease. Movement Disorders. 22(3). 389–392. 8 indexed citations

12.

Ross, Owen A., David Gosal, Jeremy T. Stone, et al.. (2007). Familial genes in sporadic disease: Common variants of α-synuclein gene associate with Parkinson's disease. Mechanisms of Ageing and Development. 128(5-6). 378–382. 51 indexed citations

13.

Healy, Daniel G., Patrick M. Abou‐Sleiman, Juan P. Casas, et al.. (2006). UCHL‐1 is not a Parkinson's disease susceptibility gene. Annals of Neurology. 59(4). 627–633. 82 indexed citations

14.

Ross, Owen A., Irene Maeve Rea, Timothy Lynch, et al.. (2004). Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish. Human Immunology. 65(4). 340–346. 54 indexed citations

15.

Khan, Abdul Sattar, Mattias Soop, Olav Rooyackers, et al.. (2003). Endotoxin-induced protein catabolism in man is closely related to the proinflammatory cytokine response. Clinical Nutrition. 22. S43–S43. 1 indexed citations

16.

Bowles, Neil E., Hua Li, J. Mark Gibson, et al.. (2002). Analysis of the coxsackievirus B-adenovirus receptor gene in patients with myocarditis or dilated cardiomyopathy. Molecular Genetics and Metabolism. 77(3). 257–259. 21 indexed citations

17.

Bowles, Karla R., et al.. (1999). Genomic Organization and Chromosomal Localization of the Human Coxsackievirus B-Adenovirus Receptor Gene. Pediatric Research. 45(4, Part 2 of 2). 20A–20A. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact